Luye Pharma Group, headquartered in Shanghai, plans to raise as much as $764 million in a Hong Kong IPO next month. The diversified pharma, which was previously listed in Singapore, was taken private in 2012 in a transaction that valued the company at $513 million. The new IPO implies a value of $2.5 billion. The parties that participated in the go-private transactions – three private equity firms, the company’s chairman and the sovereign fund of Singapore – will sell shares in the IPO.
Help employers find you! Check out all the jobs and post your resume.
